Volaco A, Cavalcanti AM, Filho RP, et al. Socioeconomic status: the missing link between obesity and diabetes mellitus? Curr Diabetes Rev. 2018;14:321–6.

Article  PubMed  Google Scholar 

Kristensen FPB, Christensen DH, Callaghan BC, et al. The prevalence of polyneuropathy in type 2 diabetes subgroups based on HOMA2 indices of beta-cell function and insulin sensitivity. Diabetes Care. 2023;46:1546–55.

Article  PubMed  CAS  Google Scholar 

Rubino F, Nathan DM, Eckel RH, et al. Metabolic surgery in the treatment algorithm for type 2 diabetes: a joint statement by International Diabetes Organizations. Diabetes Care. 2016;39:861–77.

Article  PubMed  CAS  Google Scholar 

Hsu CC, Almulaifi A, Chen JC, et al. Effect of bariatric surgery vs medical treatment on type 2 diabetes in patients with body mass index lower than 35: five-year outcomes. JAMA Surg. 2015;150:1117–24.

Article  PubMed  Google Scholar 

Kenngott HG, Clemens G, Gondan M, et al. DiaSurg 2 trial–surgical vs. medical treatment of insulin-dependent type 2 diabetes mellitus in patients with a body mass index between 26 and 35 kg/m2: study protocol of a randomized controlled multicenter trial–DRKS00004550. Trials. 2013;14:183.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Ribaric G, Buchwald JN, McGlennon TW. Diabetes and weight in comparative studies of bariatric surgery vs conventional medical therapy: a systematic review and meta-analysis. Obes Surg. 2014;24:437–55.

Article  PubMed  CAS  Google Scholar 

Welbourn R, Hollyman M, Kinsman R, et al. Bariatric surgery worldwide: baseline demographic description and one-year outcomes from the Fourth IFSO Global Registry Report 2018. Obes Surg. 2019;29:782–95.

Article  PubMed  Google Scholar 

Kermansaravi M, Parmar C, Chiappetta S, et al. Patient selection in one anastomosis/mini gastric bypass-an expert modified delphi consensus. Obes Surg. 2022;32:2512–24.

Article  PubMed  Google Scholar 

Shivakumar S, Tantia O, Goyal G, et al. LSG vs MGB-OAGB-3 year follow-up data: a randomised control trial. Obes Surg. 2018;28:2820–8.

Article  PubMed  CAS  Google Scholar 

Abu-Abeid A, Lessing Y, Pencovich N, et al. Diabetes resolution after one anastomosis gastric bypass. Surg Obes Relat Dis. 2018;14:181–5.

Article  PubMed  Google Scholar 

Singh B, Saikaustubh Y, Singla V, et al. One Anastomosis Gastric Bypass (OAGB) vs Roux en Y Gastric Bypass (RYGB) for remission of T2DM in patients with morbid obesity: a randomized controlled trial. Obes Surg. 2023;33:1218–27.

Article  PubMed  Google Scholar 

Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Int J Surg. 2021;88: 105906.

Article  PubMed  Google Scholar 

Shea BJ, Reeves BC, Wells G, et al. AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. BMJ. 2017;358: j4008.

Article  PubMed  PubMed Central  Google Scholar 

Sterne JAC, Savovic J, Page MJ, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366: l4898.

Article  PubMed  Google Scholar 

Egger M, Smith GD, Phillips AN. Meta-analysis: principles and procedures. BMJ. 1997;315:1533–7.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539–58.

Article  PubMed  Google Scholar 

Sterne JA, Sutton AJ, Ioannidis JP, et al. Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ. 2011;343: d4002.

Article  PubMed  Google Scholar 

Seetharamaiah S, Tantia O, Goyal G, et al. LSG vs OAGB-1 year follow-up data-a randomized control trial. Obes Surg. 2017;27:948–54.

Article  PubMed  Google Scholar 

Level L, Rojas A, Pinango S, et al. One anastomosis gastric bypass vs. Roux-en-Y gastric bypass: a 5-year follow-up prospective randomized trial. Langenbecks Arch Surg. 2021;406:171–9.

Article  PubMed  Google Scholar 

Lee WJ, Chong K, Ser KH, et al. Gastric bypass vs sleeve gastrectomy for type 2 diabetes mellitus: a randomized controlled trial. Arch Surg. 2011;146:143–8.

Article  PubMed  Google Scholar 

Lee WJ, Chong K, Lin YH, et al. Laparoscopic sleeve gastrectomy versus single anastomosis (mini-) gastric bypass for the treatment of type 2 diabetes mellitus: 5-year results of a randomized trial and study of incretin effect. Obes Surg. 2014;24:1552–62.

Article  PubMed  Google Scholar 

Jain M, Tantia O, Goyal G, et al. LSG vs MGB-OAGB: 5-year follow-up data and comparative outcome of the two procedures over long term-results of a randomised control trial. Obes Surg. 2021;31:1223–32.

Article  PubMed  Google Scholar 

Robert M, Espalieu P, Pelascini E, et al. Efficacy and safety of one anastomosis gastric bypass versus Roux-en-Y gastric bypass for obesity (YOMEGA): a multicentre, randomised, open-label, non-inferiority trial. Lancet. 2019;393:1299–309.

Article  PubMed  Google Scholar 

Pu YD, Li JQ, Cao ZY, et al. Clinical observation of gastric bypass in treatment of type 2 diabetes. Chin Med J (Engl). 2012;125:1899–902.

PubMed  Google Scholar 

Saeedi P, Petersohn I, Salpea P, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9(th) edition. Diabetes Res Clin Pract. 2019;157: 107843.

Article  PubMed  Google Scholar 

Group GSR, Nathan DM, Lachin JM, et al. Glycemia reduction in type 2 diabetes - microvascular and cardiovascular outcomes. N Engl J Med. 2022;387:1075–88.

Article  Google Scholar 

Mingrone G, Panunzi S, De Gaetano A, et al. Metabolic surgery versus conventional medical therapy in patients with type 2 diabetes: 10-year follow-up of an open-label, single-centre, randomised controlled trial. Lancet. 2021;397:293–304.

Article  PubMed  Google Scholar 

De Luca M, Zese M, Bandini G, et al. Metabolic bariatric surgery as a therapeutic option for patients with type 2 diabetes: a meta-analysis and network meta-analysis of randomized controlled trials. Diabetes Obes Metab. 2023;25:2362–73.

Article  PubMed  Google Scholar 

Schauer PR, Bhatt DL, Kirwan JP, et al. Bariatric surgery versus intensive medical therapy for diabetes - 5-year outcomes. N Engl J Med. 2017;376:641–51.

Article  PubMed  PubMed Central  Google Scholar 

De Luca M, Piatto G, Merola G, et al. IFSO update position statement on One Anastomosis Gastric Bypass (OAGB). Obes Surg. 2021;31:3251–78.

Article  PubMed  Google Scholar 

Taha O, Abdelaal M, Abozeid M, et al. Outcomes of one anastomosis gastric bypass in 472 diabetic patients. Obes Surg. 2017;27:2802–10.

Article  PubMed  Google Scholar 

Bettini S, Segato G, Prevedello L, et al. Improvement of lipid profile after one-anastomosis gastric bypass compared to sleeve gastrectomy. Nutrients. 2021;13:2770–80.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Salminen P, Gronroos S, Helmio M, et al. Effect of laparoscopic sleeve gastrectomy vs Roux-en-Y gastric bypass on weight loss, comorbidities, and reflux at 10 years in adult patients with obesity: the SLEEVEPASS randomized clinical trial. JAMA Surg. 2022;157:656–66.

Article  PubMed  PubMed Central  Google Scholar 

Riddle MC, Cefalu WT, Evans PH, et al. Consensus report: definition and interpretation of remission in type 2 diabetes. Diabetes Care. 2021;44:2438–44.